Description

The Diabetes Test Kit YRA341// YRA344 is a comprehensive solution for diagnosing diabetes with precision and reliability. This cutting-edge kit employs advanced chemiluminescence technology to provide accurate readings for essential markers such as C-Peptide (C-P), Insulin (INS), Glutamic Acid Decarboxylase 65 (GAD65), and Insulin Antibodies (INS-AB). Designed for use with CLIA Analyzers like YR06389 and YR06390, this kit offers unparalleled sensitivity and stability, enhancing the detection of small molecules, thanks to its patented enzyme label and magnetic bead and substrate solution technologies.

One of the significant advantages of the Diabetes Test Kit YRA341//YRA344 is its automated operation, making it ideal for fast-paced laboratory environments. Utilizing unique magnetic separation technology, it reduces manual intervention and ensures rapid results without compromising accuracy. Additionally, the kit is designed with safety in mind, completely eliminating any radioactive hazards. The combination of these features makes it a reliable choice for healthcare professionals worldwide.

For organizations looking to integrate this kit into their diagnostic arsenal, Kalstein Plus provides an easy and efficient way to request a quote or generate an automatic quotation online. With certification from CE, ISO13485, and FSC, you can trust the quality and compliance of the Diabetes Test Kit YRA341//YRA344 with international standards.

Market Price

The price of diabetes test kits in the market can vary based on features, brand reputation, and buying agreements. The Diabetes Test Kit YRA341//YRA344 is competitively priced to provide excellent value. While exact prices may fluctuate, the kit is generally positioned within a mid-to-high range, reflecting its advanced technology and robust results. To obtain the best pricing, customers are encouraged to contact suppliers directly or request quotes via the Kalstein Plus platform.

Frequently Asked Questions

What parameters does the kit test for? The kit tests for C-Peptide, Insulin, Glutamic Acid Decarboxylase 65, and Insulin Antibodies.

Is the kit compatible with all CLIA Analyzers? The Diabetes Test Kit is specifically compatible with CLIA Analyzers YR06389 and YR06390.

How should the kit be stored? The kit must be stored at temperatures between 2-8°C to maintain its efficacy.

Advantages and Disadvantages

The Diabetes Test Kit YRA341//YRA344 offers numerous advantages, including high sensitivity, stability, fast response times, and automation compatibility. Its safety features, such as the elimination of radioactive hazards, enhance its appeal. However, potential disadvantages might include a higher initial cost compared to basic kits and the need for appropriate analyzer compatibility. Users should weigh these factors when making purchasing decisions.

Use of Product in the Field

Within laboratory settings, the Diabetes Test Kit YRA341//YRA344 enables efficient and precise testing for diabetes markers. Its easy-to-use design supports seamless integration into existing workflows, minimizing delays and improving testing throughput. Healthcare professionals can quickly adapt to its straightforward operation, ensuring timely and accurate diagnostics.

Recommendations

To maximize the utility of the Diabetes Test Kit YRA341//YRA344, it is advised to follow storage guidelines rigorously. Laboratories should ensure compatibility with the specified CLIA analyzers for best results. Regular training and updates on the operation can further enhance testing efficiency and accuracy.

Features

• Advanced chemiluminescence technology
• High stability and sensitivity
• Unique magnetic separation for automation
• No radioactive hazards
• Compatible with specific CLIA analyzers

Technical Specifications